• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT AORTIC PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT AORTIC PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART VALVE Back to Search Results
Model Number 2700
Device Problems Calcified (1077); Torn Material (3024)
Patient Problem Aortic Insufficiency (1715)
Event Date 04/20/2015
Event Type  Injury  
Event Description
Edwards received information that this aortic valve was explanted after approx.Eleven (11) years, three (3) months due to insufficiency secondary to calcification.As reported, the leaflets had moderate to severe calcification and also exhibited a tear.This was replaced with a 23mm pericardial bioprosthesis.The patient remained stable and was returned to the surgical intensive care unit.
 
Event Description
Edwards received additional information indicating the implant duration of this device was twelve (12) years, three (3) months.
 
Manufacturer Narrative
Evaluation summary: the explanted device was returned to edwards for analysis.As received, the valve's suture ring was cut into pieces, exposing the wireform around a leaflet.The x-ray demonstrated heavy calcification in the cusp area of all three (3) leaflets.One (1) leaflet was torn along the commissure and on the cusp area along the wireform.Another leaflet was torn at the free margin and into the cusp area.Tissue swelling was observed on the free margin of all leaflets and there was a gap in the central coaptation region.Heavy host tissue overgrowth encroached onto the tissue and into the orifice and on a leaflet at the outflow and inflow aspect.Host tissue was minimal around the stent circumference at the outflow and inflow aspect.Hematoma was observed on two (2) leaflets on the outflow aspect.Method: #86 = x-ray.The clinical observation of calcification could be confirmed as calcification restricted mobility in the leaflets and led to stenosis.Calcification plays a major role in the failure of bioprosthetic heart valves and many factors contribute to its onset and propagation.These include patient factors (age, disease state, pharmacological intervention, etc.) and mechanical stress related to the valve's hemodynamic performance.Though numerous studies have been conducted on preventive calcification strategies in bioprosthetic heart valves, the causes of calcification are not fully understood and there are still no mechanisms or medical therapies which fully prevent bioprostheses from calcifying.Edwards will continue to review and monitor all events.If further information becomes available, a follow-up report will be submitted.
 
Manufacturer Narrative
Additional manufacturer narrative: the device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.Reference mfr # 2015691-2015-01163.Describe event of problem : edwards received additional information indicating the implant duration of this device was twelve (12) years, three (3) months.Implant date : (b)(6) 2003.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PERIMOUNT AORTIC PERICARDIAL BIOPROSTHESIS
Type of Device
REPLACEMENT HEART VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
one edwards way
irvine CA 92614
Manufacturer Contact
neil landry
1 edwards way
ms: lfs 33
irvine, CA 92614
9492502289
MDR Report Key4782962
MDR Text Key5798226
Report Number2015691-2015-01161
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860057
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/20/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/19/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2006
Device Model Number2700
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/07/2015
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/22/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/13/2002
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age73 YR
-
-